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Abstract
Background—Obstructive sleep apnea (OSA) predisposes individuals to cardiovascular
morbidity, and cardiopulmonary exercise test (CPET) markers prognostic for cardiovascular
disease have been found to be abnormal in adults with OSA. Due to the persistence of OSA and its
cardiovascular consequences, whether the cardiovascular adaptations normally conferred by
exercise are blunted in adults not utilizing established OSA treatment is unknown. The aims of
this study were to document whether OSA participants have abnormal CPET responses and
determine whether exercise modifies these CPET markers in individuals with OSA.
Methods—The CPET responses of 43 sedentary, overweight adults (body mass index [BMI]>25)
with untreated OSA (apnea-hypopnea index [AHI]≥15) were compared against matched non-OSA
controls (n=9). OSA participants were then randomized to a 12-week exercise training (n=27) or
stretching control treatment (n=16), followed by a post-intervention CPET. Measures of resting,
exercise, and post-exercise recovery heart rate (HRR), blood pressure, and ventilation, as well as
peak oxygen consumption (VO2peak), were obtained.
Results—OSA participants had blunted HRR compared to non-OSA controls at 1 (P=.03), 3 (P=.
02), and 5 min post-exercise (P=.03). For OSA participants, exercise training improved VO2peak
(P=.04) and HRR at 1 (P=.03), 3 (P<.01), and 5 min post-exercise (P<.001) compared to control.
AHI change was associated with change in HRR at 5-min post-exercise (r=−.30, P<.05), but no
other CPET markers.
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Conclusions—These results suggest that individuals with OSA have autonomic dysfunction,
and that exercise training, by increasing HRR and VO2peak, may attenuate autonomic imbalance
and improve functional capacity independent of OSA severity reduction.
Keywords
obstructive sleep apnea; exercise testing; exercise training; heart rate recovery; peak oxygen
consumption
INTRODUCTION
Obstructive sleep apnea (OSA) imposes numerous consequences on the cardiovascular
system and, without treatment, predisposes to significant cardiovascular disease (CVD)
morbidity and mortality [1–3]. The cardiovascular consequences of OSA are thought to be
primarily due to the intermittent hypoxia and arousals resulting from recurring apneic and
hypopneic events [4]. The subsequent sympathetic nervous system (SNS) hyperactivity,
systemic inflammation, and endothelial dysfunction are believed to be integral intermediate
mechanisms of CVD pathology in OSA [5,6].
Cardiopulmonary exercise testing (CPET) provides important prognostic information
regarding future cardiovascular health, even in apparently healthy individuals [7–10]. In
adults with untreated OSA, many CPET responses have been found to be abnormal when
compared with age-, activity- and weight-matched non-OSA controls [11]. These abnormal
CPET responses have included reduced cardiorespiratory fitness (VO2peak) [12–14],
chronotropic impairment [15], exaggerated systolic (SBP) and/or diastolic blood pressure
(DBP) [13,16], impaired ventilatory efficiency (VE/VCO2 slope) [17], and blunted heart rate
recovery (HRR) [14,18].
Exercise training has well-established benefits for cardiovascular health [19]. In populations
with elevated CVD risk, exercise has elicited increases in VO2peak [20] and HRR [21,22]
and reductions in ventilatory inefficiency [23]. However, the effect of exercise on
cardiovascular adaptations in OSA patients is largely unknown. Without amelioration of the
frequent night-time SNS surges and intermittent hypoxia by OSA treatment (e.g., continuous
positive airway pressure [CPAP]), persistent SNS hyperactivity and systemic inflammation
may blunt adaptations normally conferred by exercise [24,25]. Indeed, in physically active
young adults, two weeks of chronic intermittent hypoxia during sleep, similar to what would
be experienced in OSA, has recently been shown to result in cardiovascular and ventilatory
impairments during exercise [26].
The aims of this study were: (1) to compare the baseline CPET responses of participants
with OSA to a control group of age- and body mass index (BMI)-matched non-OSA adults
(who were not subsequently randomized to an intervention), and (2) to evaluate whether
CPET responses were altered in participants with OSA following exercise training versus a
stretching control treatment. The outcomes presented here were part of a parent randomized
controlled trial of exercise training on the severity of OSA, the results of which have been
previously published [27].
MATERIALS AND METHODS
Participant Recruitment and Screening
Adults with at least moderate-severity OSA (apnea-hypopnea index [AHI] ≥ 15) but without
current treatment for OSA were eligible to participate. Inclusion criteria included being ages
18–55 yr, overweight/obese (BMI ≥ 25), sedentary (< 2 exercise bouts/week), and being at a
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stable weight (i.e., weight ± 2 kg over last 3 months, not engaged in weight loss efforts).
Individuals were excluded for known or suspected significant cardiovascular, pulmonary or
metabolic disease [28], uncontrolled hypertension (> 159/99 mmHg), use of beta-blocker
medication, pregnancy, or health problems that contraindicated exercise. Due to the high
prevalence of hypertension in this population [2], use of antihypertensive medication was
not a reason for exclusion provided that the dose remained stable during the study and the
medication was not known to alter the chronotropic response to exercise.
Recruitment occurred through sleep medicine clinic referrals and media advertisements.
Following a phone screening to determine initial eligibility, individuals were mailed
additional screening materials that included the Berlin Questionnaire [29] and questionnaires
pertaining to health history, medication use and OSA-specific symptoms. Individuals
previously diagnosed with OSA or classified as “high risk” for OSA based on the Berlin
Questionnaire and otherwise eligible were initially enrolled in the study. Prior to
participation, all participants were briefed about the study protocol and signed an informed
consent form approved by the Institutional Review Boards of the WJB Dorn VA Medical
Center and the University of South Carolina. Following initial enrollment, 75 individuals
were scheduled for one night of laboratory polysomnography (PSG) to screen for OSA.
Individuals with a screening AHI < 15 (n = 24) were excluded from the intervention portion
of the study. However, a subset of these individuals with AHI < 10 and similar age and BMI
to participants with OSA (n = 9) was invited to continue undergoing the baseline
assessments and serve as non-OSA controls for Aim 1 of the present study.
Baseline cardiopulmonary exercise testing (CPET) and body composition assessments were
conducted on separate days over a 7–10 day period for the remaining 51 prospective
participants with a screening AHI ≥ 15. In addition to serving as a baseline assessment, the
CPET also served as a final screen for possible adverse responses to exercise. Individuals
with CPET responses suggestive of significant CVD (e.g., ST-segment changes, severe DBP
hypertension) were excluded from further participation and referred to cardiologist care (n =
3, all OSA participants). Five additional participants withdrew from the study prior to the
completion of baseline assessments.
Participants with significant OSA (i.e., a screening AHI ≥ 15) underwent another night of
laboratory PSG, which served as their baseline measure of sleep quality and OSA severity.
Once baseline assessments were complete, the OSA participants (n = 43) were randomized
to either a 12-week stretching control or an exercise training treatment. After completion of
the intervention, OSA participants completed the same assessments as performed at baseline
following a day of non-exercise. The subset of non-OSA controls did not participate in the
12-week intervention and were not assessed following baseline measurements.
Polysomnographic Assessment
A standard recording montage was used for the laboratory PSG [30]. Time in bed was fixed
at 8 h and initiated according to the participant's usual bedtime. Sleep stage and respiratory
event scoring were performed according to standard criteria [30] by a registered
polysomnographic technician blinded to participant status. The AHI (calculated as the
number of apneas and hypopneas per hour of sleep), oxygen desaturation index (ODI; the
number of oxyhemoglobin saturation [SaO2] reductions ≥ 4% per hour of sleep), and the
percentage of total sleep time with SaO2 < 90% (SaO290) were retained as markers of OSA
severity.
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Cardiopulmonary Exercise Testing
At baseline for non-OSA controls and pre- and post-intervention for OSA participants, a
physician-supervised CPET was completed on a day separate from PSG testing. Participants
were asked to abstain from caffeine and other stimulants on the day of testing; however,
regular medications were allowed provided they did not have a known chronotropic effect.
Testing always occurred between 10:00–14:00 h. Following a 5-min seated rest, resting HR
and blood pressure (BP) were assessed [28]. Participants were then prepared for testing with
12-lead ECG (Quinton Q-Stress, Bothell, WA), which was monitored continuously.
The Bruce treadmill protocol [28], with an additional introductory stage of 1.7 mph and 5%
incline, was utilized for testing. Participants exercised until volitional fatigue, then
recovered for 5 min at 1.7 mph and 0% incline. Heart rate was recorded via ECG each
minute, and BP was assessed via manual sphygmomanometry every 3 min during the test, at
immediate post-exercise, and 3 min and 5 min into recovery. Respiratory gas exchange
measurements were collected on a breath-by-breath basis and condensed to 15-s averages
using a computerized metabolic cart (Cosmed Quark PFT Ergo, Rome, Italy), calibrated
before each test.
Peak oxygen consumption (VO2peak) was determined by the highest 15-sec VO2 value
obtained. The chronotropic response to exercise was assessed by the percentage of HR
reserve achieved, calculated as [(HRpeak – HRrest)/(age-predicted maximum HR [APMHR]
– HRrest)], where APMHR was estimated as (220 – age) [10]. Heart rate recovery (HRR)
was defined as the difference in beats/min between HRpeak and HR at 1 min, 3 min and 5
min into recovery (HRR-1, HRR-3, HRR-5, respectively) [9]. Recovery SBP and DBP were
calculated as the percentage of SBP and DBP at 3 min into recovery divided by SBPpeak and
DBPpeak, respectively [18]. As an index of ventilatory efficiency, the VE/VCO2 slope was
calculated as the slope of the relationship between ventilation (VE) and carbon dioxide
output (VCO2) plotted from exercise onset to maximal exercise [23].
Body Composition and Lifestyle Behaviors
Height and weight measurements were obtained using standardized procedures [28]. Total
body dual energy x-ray absorptiometry (DXA; Lunar Prodigy, GE Medical Systems,
Madison, WI) measured body fat percentage. One technician conducted and analyzed all
DXA scans. Quality assurance tests and phantom scans were performed prior to all
measurement sessions. Because one OSA participant exceeded the weight limit for the DXA
machine, n = 42 was used for all DXA analyses involving OSA participants.
Daily steps were recorded with daily use of a piezoelectric pedometer (NL1000, New
Lifestyles Inc., Lees Summit, MO). The Rapid Eating Assessment for Participants-Short
Version questionnaire (REAP-S) [31] assessed dietary habits.
Treatments
Following baseline assessment, the OSA participants were randomized by a 3:2 ratio to
exercise and stretching control treatments, respectively. Randomization was stratified based
upon sex and severity of OSA (AHI 15–30 vs. AHI > 30).
Exercise Training—Participants assigned to the exercise training treatment met 4 times
per week for 12 weeks under supervised conditions. The aerobic exercise dose, which
consisted of treadmill and elliptical exercise, was gradually increased during the initial 4
weeks of the intervention. Aerobic activity, which began at 50 min distributed over 4
sessions during the initial week of the intervention, was increased by 25 min/week through
week 4. For weeks 5–12 of the intervention, the aerobic exercise dose was 150 min/week
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distributed over 4 sessions. Aerobic exercise intensity was at 60% of HR reserve and
monitored with telemetry (FS2, Polar Electro Oy, Kempele, Finland). A 5-min warm-up and
cool-down preceded and followed each aerobic exercise session, not included in the
prescribed duration.
Resistance exercise followed aerobic activity on 1–2 days/week. As with aerobic activity,
the dose of resistance exercise was gradually increased during the initial 4 weeks of the
intervention. During weeks 1 through 4, 1 set of 10–12 repetitions was performed for 8
different resistance exercises, either once per week (weeks 1 and 2) or twice per week
(weeks 3 and 4). For weeks 5–12 of the intervention, 2 sets of 10–12 repetitions for 8
exercises were performed twice per week. The specific exercises that were performed (along
with their targeted muscle groups) included the shoulder press (deltoids), lat pulldown
(latissimus dorsi), leg extension/curl (alternated between sessions; quadriceps and
hamstrings, respectively), chest press (pectorals), upright row (trapezius), seated leg press
(gluteus maximus, hamstrings, quadriceps, gastrocnemius, soleus), biceps curls/triceps
extension (alternated between sessions; biceps and triceps, respectively) and abdominal curls
(rectus abdominis). Resistance was increased on an exercise once 12 repetitions could be
performed on the second set with proper form.
Stretching Control—Participants assigned to the stretching treatment met twice/week for
12 weeks for supervised flexibility training sessions. At each visit, participants performed 2
sets of 12–15 stretches, each held for 15–30 s, that focused on whole-body flexibility. No
change in OSA severity was expected from this control treatment.
Statistical Power
This study was ancillary to a parent study that evaluated the effects of exercise training on
OSA severity [27], and was originally powered to detect changes in AHI. However, the
primary outcome of interest for these analyses was HRR-1. For Aim 1, prior research
indicated a HRR-1 of 16.2 ± 6.5 beats for adults with OSA and 23.2 ± 6.8 beats for non-
OSA adults [13,14,18,32]; statistical power was 80% to detect an identical difference
between 40 OSA and 9 non-OSA adults. For Aim 2, statistical power was 72% to detect a
HRR-1 improvement of 4.5 beats/min following exercise training, assuming a HRR-1
change standard deviation of 5.5 beats/min and no HRR-1 change in the control condition,
with a total of 40 participants randomized by a 3:2 ratio.
Statistical Analysis
Comparisons between non-OSA controls and OSA participants on baseline characteristics
and CPET responses were made with independent t-tests or χ2 tests as appropriate.
Associations between CPET responses and markers of OSA severity were evaluated with
Pearson product-moment correlations (r). For OSA participants, analyses were based on an
intent-to-treat plan, with the last observation carried forward in the case of drop-outs or
missing data. Changes in CPET responses were evaluated by analysis of covariance of post-
intervention CPET values with control for baseline CPET values. Pearson correlations (r)
between changes in CPET responses and changes in OSA severity were also performed.
All analyses were completed using SAS version 9.2 (SAS Institute, Cary, NC). Unless
otherwise specified, data are presented as mean ± standard error. All tests were two-tailed,
with statistical significance set at P < .05.
Kline et al. Page 5
Int J Cardiol. Author manuscript; available in PMC 2014 August 20.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
RESULTS
Baseline Characteristics
Table 1 provides a summary of the baseline characteristics of the participants. No significant
differences in age, BMI, body fat, or daily activity were noted between non-OSA and OSA
participants. As expected, OSA participants had significantly higher AHI (t50 = 2.73, P < .
01), ODI (t50 = 2.71, P < .01), and SaO290 (t50 = 2.06, P = .04) than non-OSA participants.
CPET Responses Between OSA and Non-OSA
A summary of the responses to CPET is given in Table 2 (left panel). Non-OSA participants
had a significantly lower HRrest than participants with OSA (t50 = 2.63, P = .01).
Chronotropic impairment was not apparent in the OSA participants, as no between-group
difference was found for HRpeak or % HR reserve attained. However, despite similar
HRpeak, HRR was significantly different between groups at each recovery time-point.
HRR-1 (t50 = −2.23, P = .03), HRR-3 (t50 = −2.32, P = .02), and HRR-5 (t50 = −2.30, P = .
03) were each significantly blunted in participants with OSA compared to non-OSA
participants. No other between-group differences in CPET responses were noted.
Associations Between CPET Responses and Markers of OSA Severity
A summary of the associations between CPET responses and markers of OSA severity is
provided in Table 2 (right panel). Markers of OSA severity were significantly correlated
with each of the HR markers; as OSA severity increased, HRrest increased, HRpeak
decreased, and HRR decreased. In addition, a significant association between DBPrest and
SaO290 was observed (r = −.28, P < .05). However, no other associations between OSA
severity and SBP, DBP, or respiratory parameters were noted.
Intervention Summary
Forty-three participants with OSA ≥ 15 at screening were randomized to exercise training (n
= 27) or stretching control (n = 16). Three exercise training participants and 2 stretching
control participants discontinued participation before study completion. As previously
reported[27], adherence did not differ between the exercise training (87.0 ± 3.7%) and the
control treatment (79.7 ± 5.2%).
Exercise training resulted in a significant (~25%) reduction in AHI (exercise: 32.2 ± 5.6 to
24.6 ± 4.4, stretching: 24.4 ± 5.6 to 28.9 ± 6.4; F1,40 = 9.54, P < .01), as previously
described [27]. Exercise training also resulted in a significant decrease in ODI (exercise:
24.5 ± 4.2 to 21.5 ± 3.7, stretching: 16.8 ± 4.2 to 23.2 ± 5.8; F1,40 = 5.05, P = .03), though
no between-treatment changes were found for SaO290. Aside from a significant
improvement in the percentage of total sleep time that was N3 sleep (i.e., slow-wave sleep)
relative to control (exercise: 12.8 ± 1.2 to 13.2 ± 1.1%, stretching: 12.4 ± 1.7 to 9.2 ± 1.5%;
F1,40 = 5.75, P = .02), PSG sleep parameters were not significantly improved following
exercise training [27]. No significant difference in body weight reduction between the two
treatments was observed (exercise: 105.6 ± 3.0 to 104.7 ± 3.1 kg, stretching: 99.3 ± 5.1 to
98.7 ± 5.0 kg) [27].
Changes in CPET Responses Following Exercise Training
Table 3 presents a summary of the changes in CPET responses between treatments.
Compared to stretching control, exercise training did not significantly change HRrest or any
HRpeak measure. However, exercise training elicited significant improvements in
cardiorespiratory fitness (F1,40 = 4.46, P = .04) and in HRR-1 (F1,40 = 4.81, P = .03), HRR-3
(F1,40 = 8.12, P < .01), and HRR-5 (F1,40 = 17.78, P < .01) compared to control (Figure 1).
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However, no between-treatment changes in the VE/VCO2 slope or any BP measure (resting,
peak, or recovery SBP or DBP) were noted.
Associations Between Changes in OSA Severity and CPET Responses
Pre- to post-intervention change in AHI was significantly correlated with change in HRR,
but only at 5 min into recovery (r = −.30, P < .05). No other significant associations were
noted between changes in CPET responses and changes in OSA severity.
DISCUSSION
Participants with OSA had a blunted HRR compared to matched non-OSA controls at
baseline, and exercise training significantly improved HRR and VO2peak in participants with
OSA. However, improvements in CPET responses were not strongly associated with
reduction in OSA severity.
Compared with BMI- and age-matched participants without OSA, OSA participants had a
significantly blunted HRR at all time-points. Furthermore, lower HRR was significantly
correlated with higher OSA severity. The blunted HRR is consistent with most prior studies
that have evaluated HRR responses in individuals with OSA [13,14,18,33,34]. As HRR is a
recognized marker of parasympathetic reactivation and SNS withdrawal, these findings
agree with previous demonstrations of autonomic dysfunction in OSA [35].
Similar HRpeak values were observed between non-OSA and OSA participants in the current
study. Whereas some studies have failed to show a blunted HR response to exercise in OSA
[12,18,33,36], others have reported significant chronotropic impairment during exercise
[13–15,32,34], and it has been hypothesized that the impairment may be due to
downregulated β-adrenergic receptors consequent to SNS hyperactivity [37]. Despite a lack
of between-group differences in HRpeak, modest correlations were observed between
measures of HRpeak and OSA severity (r = −.24 to −.42), suggesting a possible dose-
response association between the chronotropic response to exercise and OSA severity [15].
We also found no evidence of reduced cardiorespiratory fitness in OSA, which is in line
with some [18,32,38], but not all prior research [12–14,34]. In studies that have reported
reduced VO2peak with OSA, it has been speculated that this impairment may be due to
hypoxia- or SNS-induced deficits in oxidative capacity [36,39,40], increased reliance on
anaerobic metabolism [36], and/or reduced cardiac output secondary to ventricular
dysfunction and increased afterload [38]. Alternatively, impaired VO2peak in OSA may not
necessarily be due to underlying cardiac or metabolic dysfunction, but rather to increased
weight and sedentary lifestyle, exacerbated by fatigue and sleepiness [12,16,18,40]. Our
results were consistent with this alternative interpretation, since the OSA and non-OSA
participants did not differ in body weight or sedentary lifestyle.
Prior findings of an exaggerated SBP and/or DBP response to maximum exercise
[13,15,16,32,36] or blunted post-exercise SBP recovery [13,32] in adults with OSA were not
replicated by our results, which are instead in agreement with other studies in which the
exercise BP response [18,32] and BP recovery [18] were found to be unaltered in individuals
with OSA. Although allowing anti-hypertensive medication for the CPET may have reduced
the likelihood of finding differences in the BP response between the two groups, a similar
proportion of OSA and non-OSA participants were on medication (OSA: 13 of 43; non-
OSA: 3 of 9), and it was deemed unsafe to have the participants undergo CPET without
these medications.
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The ventilatory response during exercise was also similar between OSA and non-OSA
groups in the current study. Two studies have noted an exaggerated ventilatory response to
exercise [17,32] for OSA patients, which is consistent with the known heightened
chemoreflex response in OSA [41]. However, our results agree with most prior research that
has failed to observe exaggerated ventilation in OSA [12,14,33,34,38].
Following the 12-week intervention, exercise training resulted in a significant improvement
in HRR at all three recovery time-points as well as an 11% improvement in VO2peak
compared to control treatment. The significant improvement in HRR with exercise training
represents improved autonomic balance, which is an important adaptation given that
autonomic dysfunction is a strong predictor of cardiovascular morbidity and mortality [42].
Moreover, the magnitude of improvement in VO2peak following exercise training is
consistent with other recent exercise trials that have involved relatively healthy yet
sedentary adult populations [20,43].
Previous exercise training studies in adults with OSA provided equivocal results regarding
whether normal cardiovascular adaptations occurred with exercise training. Norman and
colleagues, who observed a 50% reduction in AHI following a 6-month exercise program,
reported an 18% improvement in exercise capacity along with 9 and 8 mmHg reductions in
resting SBP and DBP, respectively [44]. Similarly, Ueno and colleagues found that exercise
training resulted in a 26% increase in VO2peak and significant decrease in muscle SNS
activity following a 4-month exercise regimen in adults with chronic heart failure and OSA
[45]. However, two other studies failed to observe significant improvements in exercise
performance or VO2peak following exercise training that reduced AHI by 25% [24,25].
Although it is possible that the lack of significant cardiovascular improvements from
exercise in the latter two studies was due to insufficient reduction of OSA severity, it is
more likely that the results were limited by small sample sizes (n ≤ 10 exercise participants
in either study) and/or insufficient exercise dose. In our sample, despite an AHI reduction of
only 25%, significant improvements in HRR and VO2peak were observed following a dosage
of exercise that was designed to comply with public health physical activity
recommendations [46]. Moreover, we found minimal associations between improvements in
HRR and VO2peak and changes in OSA severity, suggesting that improvements in these
CPET markers were largely independent of reductions in OSA severity.
By minimizing the occurrence of night-time respiratory events, CPAP has been shown to
address many of the mechanisms that could cause the abnormal CPET responses seen in
adults with untreated OSA (e.g., SNS hyperactivity, cardiac dysfunction) [38,47]. However,
few studies have documented increases in VO2peak [48,49] and HRR [49] following CPAP
treatment similar to the present study's findings, and others have failed to note VO2peak
improvements with CPAP use [38,50]. As the effects of CPAP on SNS hyperactivity are
dependent upon compliance [51] and lost with CPAP withdrawal [52], exercise training may
be a beneficial adjunct therapy to promote cardiovascular health in adults with OSA.
A study limitation was the lack of randomization of non-OSA participants into the 12-week
intervention. Exercise training in these participants would have permitted direct comparison
of whether the adaptations conferred from exercise were similar between OSA and non-
OSA groups. An additional limitation was a lack of SNS activity or cardiac function
measurement, which limited our ability to interpret the mechanisms underlying the results.
Although elucidation of the possible physiological mechanisms behind abnormal CPET
responses [12,38] was not the purpose of the present study, future studies should endeavor to
investigate the mechanisms behind the blunted HRR response in OSA and how exercise may
improve autonomic function in OSA.
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In summary, this study provides evidence of blunted HRR in individuals with OSA
compared with matched non-OSA adults. Moreover, exercise training significantly
improved HRR among participants with OSA, and also resulted in increased VO2peak.
Importantly, these improvements were generally not associated with changes in OSA
severity. Thus, in light of the significant cardiovascular risk in this population, these data
suggest that exercise training may be an important therapy for improving the cardiovascular
health profile in adults with OSA, regardless of whether significant AHI reduction is
achieved.
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Figure 1.
Between-treatment changes in heart rate recovery following the intervention. Data are
presented as mean ± standard error. * indicates significant difference between stretching
control and exercise training participants (P < .05).
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Table 1
Baseline Characteristics of Non-OSA and OSA Participants.
Non-OSA (n = 9) OSA (n = 43)
Age 46.5 (2.9) 46.9 (1.2)
Sex, M/F 5/4 24/19
BMI 32.5 (1.2) 34.8 (0.9)
DXA total BF %1 41.6 (2.3) 41.6 (1.4)
Pedometer steps/day 5887.5 (543.8) 5579.8 (408.6)
REAP-S 26.0 (2.1) 26.3 (0.7)
AHI 4.7 (0.9) 29.3 (4.1)*
ODI 3.2 (0.7) 21.6 (3.1)*
SaO290 0.5 (0.2) 4.6 (0.9)*
All data are presented as mean (standard error) unless otherwise noted. AHI: apnea-hypopnea index; BMI = body mass index; DXA: dual x-ray
absorptiometry; MVPA: moderate- to vigorous-intensity physical activity; ODI: oxygen desaturation index; OSA: obstructive sleep apnea; REAP-
S: Rapid Eating Assessment for Participants-Short version; SaO290: percentage of total sleep time with SaO2 < 90%.
1
n = 42 for OSA participants.
*Significantly different between OSA and non-OSA participants (P < .05).
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Table 3
CPET Responses in OSA Participants Before and Following the Intervention.
Stretching Control (n = 16) Exercise Training (n = 27)
CPET Variable BL POST BL POST
HRrest, bpm 78.3 (3.1) 77.4 (2.6) 81.2 (1.8) 75.4 (1.7)
HRpeak, bpm 168.0 (3.1) 167.7 (3.5) 161.5 (2.9) 159.9 (2.9)
% Heart rate reserve 93.3 (2.5) 93.2 (3.5) 87.9 (2.8) 86.7 (2.4)
SBPrest, mmHg 132.4 (3.7) 125.1 (3.1) 136.4 (3.1) 129.7 (2.2)
SBPpeak, mmHg 182.6 (5.5) 187.8 (5.3) 189.1 (4.7) 195.9 (3.9)
Recovery SBP3, % peak 89.1 (1.6) 85.4 (1.4) 89.2 (1.3) 86.4 (1.3)
DBPrest, mmHg 84.7 (2.3) 82.0 (2.3) 81.3 (1.8) 81.3 (1.4)
DBPpeak, mmHg 91.1 (2.5) 84.5 (2.1) 82.5 (2.6) 83.0 (2.2)
Recovery DBP3, % peak 96.8 (1.7) 99.1 (1.7) 101.1 (1.6) 95.1 (1.8)
Peak RER 1.18 (0.03) 1.20 (0.03) 1.20 (0.03) 1.21 (0.03)
VO2peak, mL/kg/min 23.2 (1.3) 23.4 (1.4) 20.6 (1.0) 22.9 (1.2)*
VE/VCO2 slope 25.8 (0.9) 26.8 (1.1) 28.0 (1.0) 27.4 (0.8)
BL: baseline; CPET: cardiopulmonary exercise testing;; HR: heart rate; OSA: obstructive sleep apnea; POST: post-intervention; RER: respiratory
exchange ratio;; VO2peak: peak oxygen consumption.
*denotes a statistically significantly difference between stretching control and exercise training participants (P < .05).
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